Upstate Active Clinical Trials
Study Title:A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 as Adjunctive Therapy in Focal-onset Epilepsy
What is the purpose of the study?To evaluate the safety, tolerability, and how effective Xen1101 is in treating adults with focal epilepsy.
Upstate Institutional Review Board (IRB) Number:1413240
Study Phase:Phase 2
Patient Age Group:Adults
Principal Investigator:Shahram Izadyar
What is involved if I participate?
- How long is the study?
24 Weeks (5-6 Months)
- Is transportation provided or reimbursed?
- Is parking provided or reimbursed?
- What tests and procedures are involved?
Physical and Neurologic examinations, Blood samples collected, Pregnancy Test, ECG
Where will the study take place?Clinical Research Unit on the 1st floor of the IHP building.
Who can I contact for more information?
Name: Muhammad M Iqbal